石四藥集團(02005.HK)獲執行董事曲繼廣增持52.4萬股

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

石四藥集團(02005.HK)獲執行董事曲繼廣增持52.4萬股

格隆匯 04-08 06:26

格隆匯4月8日丨根據聯交所最新權益披露資料顯示，2024年4月5日，石四藥集團(02005.HK)獲執行董事曲繼廣在場內以每股均價4.8152港元增持52.4萬股，涉資約252.32萬港元。

增持後，曲繼廣最新持股數目為1,115,906,000股，持股比例由37.57%上升至37.58%。

石四藥集團(02005.HK)

Relevant Stocks

石四藥集團(02005.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

石四藥集團(02005.HK)獲執行董事曲繼廣增持52.4萬股

Services

About Us

Agreement Statement